微RNA在胰腺癌中的功能和潜在治疗作用
Amartya Pal1,2, Anushka Ojha1,2, Jingfang Ju1,3
1Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
International journal of molecular sciences
|December 23, 2023
概括
微RNAs (miRNAs) 在早期胰腺癌检测和治疗方面表现有前途. 本综述探讨了基于miRNA的疗法,包括恢复抑制瘤的miRNA和抑制瘤的miRNA,以提高患者的生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 胰腺癌的5年生存率很低,这对全球健康构成了重大挑战.
- 晚期诊断和瘤异质性阻碍了有效的治疗策略.
- 新型生物标志物对于早期检测和改善治疗干预至关重要.
研究的目的:
- 审查微RNAs (miRNAs) 在胰腺癌中的作用.
- 探索miRNAs作为诊断和治疗药物的潜力.
- 总结基于miRNA的胰腺癌治疗策略的进展.
主要方法:
- 关于胰腺癌中miRNA表达和功能研究的文献综述.
- 对基于miRNA的治疗方法的研究进行分析.
- 检查miRNA疗法的挑战和未来方向.
主要成果:
- 失调的miRNAs与胰腺癌的进展,转移和化学抵抗有关.
- 不同的miRNA表达特征为新的治疗策略提供了潜力.
- 基于miRNA的疗法,包括恢复或抑制,显示出希望.
结论:
- 微RNA在胰腺癌的发病过程中至关重要,并代表着有前途的生物标志物.
- 尽管面临挑战,但基于miRNA的疗法有可能彻底改变胰腺癌治疗.
- 向性传递和特异性是miRNA疗法的未来发展的关键领域.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


